<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201007048967N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-12-20</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of positioning with an octopus doll on the behavioral responses of premature infants under non-invasive ventilation</public_title>
      <acronym></acronym>
      <scientific_title>The effect of positioning with an octopus doll on the behavioral responses of premature infants under non-invasive ventilation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>25</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/51559</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Crossover, Purpose: Supportive, Randomization description: Samples will be randomly assigned to two groups using the envelope method. This is how the envelopes will be prepared and printed by one of the members of the research team and random numbers with the help of Randomaize.com site and will be placed inside the envelope. The lid of the envelope will be closed and its contents will not be visible from the outside. Then, the purpose of the study is first explained to the infant's parents, and if they wish, they sign the informed consent form and take an envelope, and then open it, and based on the contents of the envelope, the infant enters the intervention or control group, Blinding description: In this study, the subjects under study who are premature infants are not aware of the study and also the analyst will be unaware of the intervention and control groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>behavioral responses of premature infants.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The infants of the first group will be placed in the fetal position for the first 2 hours and then in the second 2 hours they will be placed in the fetal position with the touch of an octopus doll. In this study, the octopus doll is placed in the baby's arms and the doll's feet are placed in contact with the baby's body and hands. And the interventions will be repeated for 3 consecutive days in a fixed evening shift. Intervention 2: Control group: In the infants of the second group, they will be in contact with the doll in the first 2 hours and the doll will be removed from the baby in the second 2 hours. For the wash out phase, the babies will be in a supine position for 2 hours.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data can potentially be shared after unidentified individuals.

When:
The start of the access period is 2 months after the results are published.

To whom:
The data will be made available to researchers working in academic and scientific institutions and to people in the relevant industry and to the relevant ministry.

Conditions:
If this study has a positive effect, the effect of touching an octopus doll on the behavioral response of a premature infant under non-invasive ventilation can be used as a useful and acceptable solution to reduce stress and help calm the infant in the neonatal intensive care unit. As a result, increased relaxation is the most important element in the development of the premature nervous system.

Where to obtain:
Kimia Razi: razik961@mums.ac.ir Phone: 09156516202
Hamidreza Behnam Vashani: behnamhr@mums.ac.ir Phone: 09151109514

How to obtain:
The applicant must communicate via the contact number and e-mail address provided.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Kimia Razi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery., Ibn Sina St, Ph.D. Intersection., Daneshgah St, Mashhad, Khorasan Razavi.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>razik961@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>kimia Razi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery., Ibn Sina St, Ph.D. Intersection., Daneshgah St, Mashhad, Khorasan Razavi.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>razik961@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Guardian parent's consent for the infant to participate in the study
infant age in the range of 28 to 34 weeks (based on LMP or sonography of the first trimester of pregnancy)
under non-invasive ventilation
maximum 24 hours after the start of non-invasive ventilation
No invasive procedure was performed on the infant 2 hours before admission to the study
no contraindications to change position
no drug use in the mother during pregnancy and postpartum
no use of drugs that affect the sleep and wake cycle of the baby such as theophylline, phenobarbital
lack Prescribing sedatives such as midazolam and fentanyl
Having an Apgar score of 5 minutes above 6
no surgery on the infant after birth</inclusion_criteria>
      <agemin>7 months</agemin>
      <agemax>8 months</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Congenital and chromosomal abnormalities
asphyxia
intracerebral hemorrhage more than first grade
sepsis
heart disease
metabolic disease
anemia
SGA and IUGR</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>P07.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>preterm infants</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The infants of the first group will be placed in the fetal position for the first 2 hours and then in the second 2 hours they will be placed in the fetal position with the touch of an octopus doll. In this study, the octopus doll is placed in the baby's arms and the doll's feet are placed in contact with the baby's body and hands. And the interventions will be repeated for 3 consecutive days in a fixed evening shift.</i_keyword>
      <i_keyword>Control group: In the infants of the second group, they will be in contact with the doll in the first 2 hours and the doll will be removed from the baby in the second 2 hours. For the wash out phase, the babies will be in a supine position for 2 hours.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Behavioral response  of premature infants (sleep, wakefulness and restlessness). Timepoint: Behavioral reactions of premature infants will be observed 2 minutes before the intervention, 2 minutes during and 2 minutes after the intervention and in each turn will be observed for 30 seconds and will be recorded in the relevant form. Method of measurement: In this study, the infant's behavioral response is assessed using the Anderson Behavioral Reaction Scoring System (ABSS), which measures the infant's behavior with sleep, wakefulness, and restlessness. This scoring system determines a baby's behavioral status based on observation of respiratory order, open or closed eyes, trunk and limb activity, and crying intensity. The scoring system consists of 12 levels and behavioral states are classified into three categories: sleep, wakefulness, and restlessness. The scores are 1-5 related to sleep, 6-8 points related to wakefulness and rest, and 9-12 points related to restlessness. Based on this ABSS tool, 2 minutes before, 2 minutes during and 2 minutes after the intervention and at each turn for 30 seconds, the reactions of the baby's behaviors will be observed and recorded in the relevant form. In the Anderson Behavior Scoring System, the infant is observed for 30 seconds and the number corresponding to the highest behavioral state observed is recorded with one exception: Conscious Inactivity, which is a desirable but relatively rare state when it occurs. It is possible even if another state with the highest number occurs in the same 30 seconds, because conscious inactivity is a desirable state in infants.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>. Timepoint: . Method of measurement: .</sec_outcome>
      <sec_outcome>. Timepoint: . Method of measurement: .</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-08-03</approval_date>
        <contact_name>Ethics Committee in Research School of Nursing and Midwifery - Mashhad University of Medical Science</contact_name>
        <contact_address>School of Nursing and Midwifery., Ibn Sina St, Ph.D. Intersection., Daneshgah St, Mashhad, Khorasan Razavi Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
